ULTRAHUMAN EIGHT LTD has a total of 18 patent applications. Its first patent ever was published in 2018. It filed its patents most often in United Kingdom, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and biotechnology are MAVERICK THERAPEUTICS INC, LAZAR GREGORY ALAN and ONCOMAX ACQUISITION CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 8 | |
#2 | United States | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Finlay William James Jonathan | 10 |
Publication | Filing date | Title |
---|---|---|
GB201914747D0 | PD1 and vegfr2 dual-binding agents | |
GB201803746D0 | PD1 binding agents | |
GB201803745D0 | PD1 binding agents |